Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.13 (
protein kinase C
)
49,245
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Neutrophils possess a classical Ca2+, phosphatidyl serine (PS) and diglyceride (DG)-dependent
protein kinase C
(beta-
PKC
) which was translocatable from cytosol to membrane in response to elevated Ca2+ in the physiologic range or to pretreatment with phorbol myristate acetate (PMA). The translocatable beta-
PKC
was purified from neutrophil membranes prepared in the presence of Ca2+, eluted with EGTA and subjected to hydroxyapatite chromatography. An 80-kDa protein possessing Ca/DG/PS-dependent
histone
phosphorylating activity was recognized by a monoclonal antibody to beta-
PKC
but not to alpha-
PKC
or gamma-
PKC
. A cytosolic kinase activity remaining after Ca(2+)-induced translocation of beta-
PKC
was dependent on PS and DG but did not require Ca2+. This novel Ca(2+)-independent, PS/DG-dependent kinase, termed
nPKC
, eluted from hydroxyapatite between alpha-
PKC
and beta-
PKC
, ran as a 76-kDa band on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and was reactive to a polyclonal consensus antibody but not to monoclonal antibodies to alpha-
PKC
, beta-
PKC
, or gamma-
PKC
. Long chain fatty acyl-CoA, but not the corresponding free fatty acids, inhibited
nPKC
in the 1-10 microM range. The chemotactic peptide fMet-Leu-Phe triggered prompt but transient increases in neutrophil long chain fatty acid acyl-CoA, suggesting that
nPKC
is regulated by fatty acyl-CoA as well as DG during neutrophil activation. Purified beta-
PKC
phosphorylated a number of cytosolic proteins in a Ca(2+)-dependent manner, including a major 47-kDa cytosolic protein, which may be implicated in superoxide anion generation. In contrast,
nPKC
did not phosphorylate the 47-kDa protein, but phosphorylated numerous cytosolic proteins in a Ca(2+)-independent manner, including a 66-kDa protein which was not phosphorylated by beta-
PKC
. Differences in location, substrate specificity, and cofactor dependence between
nPKC
and beta-
PKC
suggest these kinases may play selective roles in the activation sequence of the neutrophil.
...
PMID:Protein kinase C isotypes and signaling in neutrophils. Differential substrate specificities of a translocatable calcium- and phospholipid-dependent beta-protein kinase C and a phospholipid-dependent protein kinase which is inhibited by long chain fatty acyl coenzyme A. 202 25
To determine the contribution of phosphate acceptor substrate to the pattern of activity of calcium-dependent, phospholipid-sensitive protein kinase (
protein kinase C
,
PKC
), we assayed cytosolic and particulate
PKC
activity for
histone
, troponin, myosin light chain (MLC), and endogenous cellular proteins in human neutrophils stimulated with phorbol myristate acetate (PMA), the chemotactic peptide n-formyl-methionyl-leucyl-phenylalanine (FMLP) and synergistic stimulation with both agonists. In general, phosphotransferase activity in neutrophil subfractions toward troponin and endogenous proteins paralleled that toward
histone
, but MLC was a poor substrate for
PKC
and the pattern of phosphotransferase activity differed from that seen with the other substrates. Furthermore, the phosphorylation of endogenous neutrophil cytosolic proteins increased significantly after stimulation with FMLP, suggesting an endogenous cytosolic substrate(s) which increased in concentration following stimulation. We conclude that
histone
is a useful phosphate acceptor for study of
PKC
activity in human neutrophils, but substrate variability occurs and may influence interpretation of results in assays of
PKC
activity.
...
PMID:Substrate dependence of human neutrophil protein kinase C. 205 46
We have examined the activity and intracellular compartmentalization of
protein kinase C
(
PKC
) following activation of human B lymphocytes by anti-human leukocyte antigen (HLA) class II antibodies. 12-O-Tetradecanoylphorbol 13-acetate (TPA) treatment increased membrane-associated
PKC
(between five and nine times greater than the control value) and decreased cytosolic
PKC
(between 70% and 100% of the control value). In contrast, anti-class II antibodies induce an activation of
PKC
which results either in an increase of cytosolic activity or membrane-bound activity without redistribution of cytosolic
PKC
. The effect of TPA and HLA class II molecules on total
PKC
activity was comparable: when TPA induced an increase of total
PKC
activity so did HLA class II molecules and when TPA did not, HLA class II molecules did not. Measurement on SDS PAGE of
histone
phosphorylation confirmed the above results of
PKC
activity. Taken together, our results suggest that
PKC
might be implicated in HLA class II-induced B lymphocyte activation.
...
PMID:Signal transduction in B lymphocytes. 205 84
The present study provides evidence that rat brain protein kinase C elicits a phosphotransferase activity towards
histone
and undergoes autophosphorylation in the absence of phosphatidylserine. The tumor promoter 12-O-tetradecanoylphorbol-13-acetate binds to and activates
protein kinase C
in a phospholipid-free reaction. The apparent activation constant (Ka = 2.7 nM) is not modified by the absence of phospholipid but the maximum velocity is greatly decreased. The phosphotransfer reaction to exogenous substrates occurs in 0.5 mM ethylene-bis(oxyethylenenitrilo)tetraacetic acid, although autophosphorylation in these conditions requires the presence of Ca2+. The protein kinase C inhibitor (1-(5-isoquinolinesulfonyl)-2-methylpiperazine inhibits the reaction, whereas the cAMP-dependent protein kinase inhibitor is ineffective. In contrast to diacylglycerol, which is a poor activator, unsaturated fatty acids potently activate the phospholipid-free reaction. Moreover, the substrate specificity is markedly changed, e.g., myelin basic protein and
histone
types VI-S and VII-S appear to be relatively better substrates in the phospholipid-free reaction. The data presented indicate that
protein kinase C
(or some individual isoforms) may function, at least partially, without binding to membrane phospholipid and suggest that this novel characteristic of phorbol esters may account for their tumor-promoting activity.
...
PMID:Phorbol esters mediate phospholipid-free activation of rat brain protein kinase C. 210 68
Intracellular growth of protozoan parasite Babesia bovis has been followed to study the effect of some chemical agents on growth regulation. Using an in vitro parasite culture system we present evidence that the normal growth of the parasite is dependent upon available calcium and a Ca2(+)-binding protein, calmodulin, because sequestration of either of these 2 components from the culture medium causes inhibition of parasitic growth. Further studies demonstrate that the parasite contains a protein kinase that can phosphorylate a 40-kDa parasitic protein and its activity is regulated by calcium and calmodulin. Both the enzyme and its substrate are present in the membrane of the parasite. In addition, the parasite also contains a highly active
protein kinase C
activity that is documented by phosphorylating
histone
, a known substrate for
protein kinase C
. These findings suggest a possible correlation between the growth of parasite and calcium/calmodulin-dependent protein phosphorylation activity.
...
PMID:Calcium-dependent protein phosphorylation in Babesia bovis and its role in growth regulation. 210 34
The regulation of
protein kinase C
by oleic acid was studied, and parameters that characterize the activation of
protein kinase C
by oleic acid and distinguish its effects from those of diacylglycerol (DAG) and phosphatidylserine (PS) were delineated. Activation of
protein kinase C
by sodium oleate required the presence of calcium and showed mild cooperative behavior (Hill number of 1.25) suggesting that Ca(oleate)2 is the active species. Kinetic analysis of the interaction of sodium oleate with substrates indicated that sodium oleate acted to increase the activity of the enzyme without modulating the KM for either MgATP or
histone
substrates. In this respect, sodium oleate action resembled that of DAG but not PS. However, multiple parameters distinguished the effects of sodium oleate from those of DAG. Unlike DAG, sodium oleate was unable to inhibit phorbol dibutyrate binding to
protein kinase C
. Sodium oleate also failed to interact with micelle-bound
protein kinase C
and preferentially activated "soluble"
protein kinase C
. The addition of
histone
caused protein/lipid aggregation in the presence of DAG but not in the presence of oleate. Activation of
protein kinase C
by sodium oleate or by PS/DAG demonstrated differential susceptibility to the action of inhibitors. Sphingosine and NaCl were more potent in inhibiting activation of
protein kinase C
by PS/DAG than by sodium oleate. Sodium oleate also expressed PS-like activity in that calcium and oleate acted as cofactors in activation of
protein kinase C
by DAG. Similar to PS, the ability of oleate to act in synergy with DAG resulted from "competitive" activation with a decrease in KM(app) of
protein kinase C
for DAG. Finally, sodium oleate was unable to induce autophosphorylation of
protein kinase C
. These studies demonstrate that oleate activates
protein kinase C
by a mechanism that is distinct from PS/DAG but partially overlaps the kinetic effects of both PS and DAG. The significance of these studies is discussed in relation to mechanisms of
protein kinase C
activation and to the possible physiological relevance of activation of
protein kinase C
by fatty acids.
...
PMID:Regulation of platelet protein kinase C by oleic acid. Kinetic analysis of allosteric regulation and effects on autophosphorylation, phorbol ester binding, and susceptibility to inhibition. 211 7
Type II and type III isoenzymes of
protein kinase C
isolated from rabbit thymus cells were activated at relatively low concentrations but were inhibited at higher concentrations of arachidonic acid. Activation by cis-unsaturated fatty acids required Ca2+; the maximal activity was approached at about 10(-6) M Ca2+ concentration. The kinetics of activation and inhibition by arachidonic acid depended strongly on the nature of the substrate (synthetic oligopeptide or H1
histone
), on the concentration of the protein substrate and on the stage of purification of the isoenzyme preparation investigated. Activation seemed to be favoured at high protein concentrations.
...
PMID:Dual effect of arachidonic acid on protein kinase C isoenzymes isolated from rabbit thymus cells. 212 8
We have previously shown that a synthetic peptide containing env residues 581-597 from HIV-1 inhibits lymphoproliferation of human PBMC. We have investigated the molecular mechanism(s) by which this HIV-1-derived peptide inhibits CD3-mediated signal transduction. We show that the peptide containing residues 581-597 from the HIV-1 transmembrane protein gp41 specifically inhibited the intracellular Ca2+ influx in Jurkat cells stimulated by the mAb OKT3 whereas it had no effect on the production of inositol triphosphate. In addition, the peptide inhibited
protein kinase C
(pkC)-mediated phosphorylation of the CD3 gamma-chain in intact cells and directly inhibited partially purified pkC. The inhibition was noncompetitive with respect to the substrates
histone
and ATP and independent of the regulatory domain of the enzyme. Furthermore, the peptide required internalization for inhibitory activity because no inhibition of lymphoproliferation was observed when cells were treated with peptide at 4 degrees C. Based on these results obtained with the peptide aa581-597, we postulate that the transmembrane protein gp41 of HIV-1 may inhibit pkC activity and thus block pkC-dependent immune function contributing to the immunosuppression of HIV-1-infected individuals.
...
PMID:Inhibition of protein kinase C and anti-CD3-induced Ca2+ influx in Jurkat T cells by a synthetic peptide with sequence identity to HIV-1 gp41. 213 76
We determined whether the beta or gamma
protein kinase C
(
PKC
) subtypes implicated in long-term potentiation (LTP) selectively regulates protein F1 phosphorylation. Purified bovine
PKC
subtypes and recombinant
PKC
subtypes activated by phosphatidylserine (PS) and calcium were tested for their relative ability to phosphorylate purified rat protein F1 (a.k.a. GAP-43). After equalizing enzyme activity against
histone
, the recombinant beta II
PKC
phosphorylated protein F1 to a 6 fold greater extent than the recombinant gamma
PKC
. Bovine beta I
PKC
phosphorylated protein F1 to a 3 fold greater extent than bovine gamma
PKC
. Even when PS was replaced by lipoxin B4, which can selectively increase gamma
PKC
activity, beta I
PKC
was still superior to gamma
PKC
in phosphorylating protein F1. Taken together with previous cellular studies of brain showing parallel levels of expression of beta
PKC
mRNA and protein F1 mRNA, the present results make it attractive to propose that beta
PKC
regulates protein F1 phosphorylation during the development of synaptic plasticity.
...
PMID:Neuron-specific protein F1/GAP-43 shows substrate specificity for the beta subtype of protein kinase C. 214 33
In view of the critical role that the Ca2+- and phospholipid-dependent enzyme
protein kinase C
(
PKC
) plays in mediating proliferative responses to a number of growth factors, hormones, and tumor promoters, it is thought that selective
PKC
inhibitors may provide a new class of antiproliferative drugs. Established
PKC
inhibitors include three major classes of agents: agents that compete with the substrate ATP, agents that compete with the protein substrate, and agents that both compete with ATP and interact with the cofactor phosphatidylserine (PS). In this report, we have characterized the interactions between
PKC
and N-myristyl-Lys-Arg-Thr-Leu-Arg, a myristylated analogue of a synthetic peptide substrate of
PKC
. We determined that the myristylated peptide was a novel
PKC
inhibitor that interacted with PS as well as competed with the protein substrate of
PKC
. The inhibitory activity of the peptide was conferred by myristylation. We found that the myristylated peptide antagonized Ca2+- and PS-activated
PKC
with an IC50 of 75 microns, whereas the nonmyristylated peptide lacked this inhibitory activity. A fully active, Ca2+- and PS-independent catalytic fragment of
PKC
can be generated by limited proteolysis. Although the myristylated peptide was a very poor
PKC
substrate, this peptide inhibited the catalytic fragment of
PKC
by apparent competition with the phosphoacceptor substrate
histone
IIIS with an IC50 of 200 microM, whereas the nonmyristylated peptide showed no inhibitory activity against the catalytic fragment. Thus, the myristylated peptide may serve as a model for the development of selective
PKC
inhibitors, because its inhibitory mechanism exploits the substrate specificity of
PKC
, as well as the novel regulation of the enzyme. Furthermore, since endogenous
PKC
substrates include acylated proteins, the observations that we report here concerning a myristylated synthetic peptide suggest that acylation of proteins may be important in the regulation of
PKC
activity in vivo.
...
PMID:N-myristyl-Lys-Arg-Thr-Leu-Arg: a novel protein kinase C inhibitor. 215 82
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>